Skip Navigation


International Immunology Advance Access originally published online on June 17, 2008
International Immunology 2008 20(8):1067-1075; doi:10.1093/intimm/dxn064
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/8/1067    most recent
dxn064v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Han, B.
Right arrow Articles by Luo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, B.
Right arrow Articles by Luo, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus

Bing Han1, Rafael Bojalil2,3, Luis M. Amezcua-Guerra2, Rashidi Springall2, Héctor Valderrama-Carvajal1, Jiangping Wu1,4 and Hongyu Luo1

1 Laboratory of Immunology, Research Centre, Centre hospitalier de l'Université de Montréal, Notre-Dame Hospital, Pavilion DeSève, Montreal, Quebec H2L 4M1, Canada
2 Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
3 Department of Health Care, Universidad Autónoma Metropolitana, Mexico City, Mexico
4 Nephrology Service, Centre hospitalier de l'Université de Montréal, Notre-Dame Hospital, Montreal, Quebec H2L 4M1, Canada

Correspondence to: H. Luo; E-mail: hongyu.luo{at}umontreal.ca; or to J. Wu; E-mail: jianping.wu{at}umontreal.ca

In this study, we investigated the diagnostic value of serum death decoy receptor 3 (DcR3) for systemic lupus erythematosus (SLE). The possible pathogenic role of DcR3 in SLE was also assessed. Serum DcR3 levels of 90 SLE patients, 11 patients with rheumatic conditions and 123 healthy controls were determined by ELISA. In all, 43% of the SLE patients, 9% of patients with rheumatic conditions and 2.4% of the normal healthy individuals presented elevated serum DcR3 levels. A higher percentage of DcR3-positive SLE patients, compared with DcR3-negative SLE patients, showed abnormally high serum IgE levels, a surrogate marker of Th2-type immune responses. To determine the cause and effect relationship of DcR3 expression and a Th2-prone status, we studied young DcR3 transgenic (Tg) mice, whose transgene was driven by an actin promoter. These mice had IL-4 overproduction and augmented serum IgE levels, signs of dominant Th2 immune responses. To determine possible SLE pathogenic roles of DcR3, the T-cell-depleted bone marrow of DcR3 Tg mice was transplanted into lethally irradiated syngeneic C57BL/6 female mice. The recipients developed an SLE-like syndrome. They presented anti-dsDNA and anti-nuclear antibodies, along with renal and liver pathology compatible with that of SLE. In total, 90% of Tg bone marrow-transplanted mice, compared with 20% of wild-type bone marrow-transplanted mice, perished within 12 months after the transplantation. Our results showed that serum DcR3 could serve as an additional parameter for SLE diagnosis and that DcR3 secreted from cells of hematopoietic origin was SLE pathogenic in mice.

Keywords: DcR3, systemic lupus erythematosus


Transmitting editor: Andras Falus

Received 3 March 2008, accepted 22 May 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
C.-Y. Chen, K.-Y. Yang, M.-Y. Chen, H.-Y. Chen, M.-T. Lin, Y.-C. Lee, R.-P. Perng, S.-L. Hsieh, P.-C. Yang, and T.-Y. Chou
Decoy Receptor 3 Levels in Peripheral Blood Predict Outcomes of Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 751 - 760.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.